{"id":130729,"title":"DSEN Abstract: Assessing the potential for additive toxicity arising from the combined use of immune checkpoint inhibitors and of tyrosine kinase inhibitors - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T11:19:30.479000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/54101.html?wbdisable=true","snippet":"DSEN Abstract: Assessing the potential for additive toxicity arising from the combined use of immune checkpoint inhibitors and of tyrosine kinase inhibitors - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services Departments Language selection Français Search and…","rawSnapshotUrl":"/api/snapshots/raw/130729","browseUrl":"https://replay.healtharchive.ca/job-2/20250410111930/https://cihr-irsc.gc.ca/e/54101.html?wbdisable=true#ha_snapshot=130729","mimeType":"text/html","statusCode":200}